Stem cells for flu? For me, that idea is new. Some months back there was buzz about the stem cell biotech Longeveron related to its report on early trial data on testing infusions of mesenchymal stem cells for frailty in the aged. Frailty that pops up in some aging folks can manifest in a variety of ways and contribute both to reduced quality of life and mortality. This week a PR firm for Longeveron sent out an email suggesting that the company’s investigational stem …Read More
Knoepfler lab stem cell blog
